A Study of AK0529 in Infants Hospitalized With RSV
Status:
Terminated
Trial end date:
2015-11-03
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, pharmacokinetics (PK) and anti-viral effect
of single dose of AK0529 in infants hospitalized with respiratory syncytial virus (RSV).